OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Your search returned 20 results. Expanded Search
Genes match for NM_018412   Similar terms to NM_018412

   ST7   (DKFZp762O2113;ETS7q;FAM4A;FAM4A1;HELG;RAY1;SEN4;TSG7;)

Citation  Cited in Publication(s)       15,000 ORF clones at $98 each


TA317371  Anti-ST7  Antibody
1 Image
Description:   ST7 Rabbit Polyclonal (aa846-859) Antibody
Applications:  IHC
Reactivity:  Tested: Human
spacer
AP54058PU-N  Anti-ST7  Antibody
2 Images
Description:  Rabbit Polyclonal Anti-ST7 Antibody, Aff - Purified
Applications:  FC, WB
Reactivity: Hu
spacer
|<<     <<      >>     >>|   total pages:1
SKU   Category   Expression Host   Description   $ Price   Availability  
  LY413067     Lysate HEK293T Transient overexpression lysate of suppression of tumorigenicity 7 (ST7), transcript variant a 480 5 days
TrueORF Gold TrueORF Gold = Expression Validated + Sequence Verified + Next-day shipment!
SKU   Category   Vector   Tag   Description   $ Price   Availability  
  RC211915     TrueORF Gold TrueORF Gold pCMV6-Entry Myc-DDK ST7 (Myc-DDK-tagged)-Human suppression of tumorigenicity 7 (ST7), transcript variant a 680 In Stock
  RC211915L1V     Human LentiORF Particles pLenti-C-Myc-DDK Myc-DDK Lenti ORF particles, ST7 (Myc-DDK tagged) - Human suppression of tumorigenicity 7 (ST7), transcript variant a , 200ul, >10^7 TU/mL 1260 6-7 weeks
  RC211915L2V     Human LentiORF Particles pLenti-C-mGFP mGFP Lenti ORF particles, ST7 (mGFP-tagged) - Human suppression of tumorigenicity 7 (ST7), transcript variant a, 200ul, >10^7 TU/mL 1380 6-7 weeks
  RC211915L1     Human Lenti-ORF pLenti-C-Myc-DDK Myc-DDK Lenti ORF clone of Human suppression of tumorigenicity 7 (ST7), transcript variant a , Myc-DDK-tagged 860 3-4 weeks
  RC211915L2     Human Lenti-ORF pLenti-C-mGFP mGFP Lenti ORF clone of Human suppression of tumorigenicity 7 (ST7), transcript variant a, mGFP tagged 940 3-4 weeks
  RG211915     Human Clone pCMV6-AC-GFP TurboGFP ST7 (GFP-tagged) - Human suppression of tumorigenicity 7 (ST7), transcript variant a 750 2-3 weeks
  SC109915     Human Clone pCMV6-XL4 No Tags ST7 (untagged)-Human suppression of tumorigenicity 7 (ST7), transcript variant a 850 In Stock
SKU   Category   Format   Vector   Description   $ Price   Availability  
  TL301361V     Human shRNA Lentiviral particles pGFP-C-shLenti ST7 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^6 TU/ml. 1200 5 weeks
  TL301361     Human shRNA Lentiviral Plasmid pGFP-C-shLenti ST7 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector 750 2 Weeks
  TG301361     Human shRNA Retroviral Plasmids pGFP-V-RS ST7 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector 650 2 Weeks
  TF301361     Human shRNA Retroviral Plasmids pRFP-C-RS ST7 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector 650 2 Weeks
  TR301361     Human shRNA Retroviral Plasmids pRS ST7 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector 650 2 Weeks
  SR305328     Human siRNA ST7 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each 300 In Stock
  TL515724     Mouse shRNA Lentiviral Plasmid pGFP-C-shLenti ST7 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector 750 2 Weeks
  TL700533     Rat shRNA Lentiviral Plasmid pGFP-C-shLenti ST7 - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector 750 2 Weeks
SKU   Category  
Description   $ Price   Availability  
  SC201661     3'-UTR Clone pMirTarget 3`UTR clone of suppression of tumorigenicity 7 (ST7) transcript variant a for miRNA target validation 510 3-4 weeks
SKU   Category   Description   $ Price   Availability  
  KN210079     CRISPR ST7 - human gene knockout kit via CRISPR 1200 4 Weeks
Circling Loader
Loading message
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title